or Try an Advanced Search...

    ETF Components for EFAD - ProShares MSCI EAFE Dividend Growers ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    DEO F -0.77 1.40
    NVS D 0.35 1.34

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Alcohol Alcoholic Drinks Animal Health Antibiotics Beer Biotechnology Blood Test Canadian Whisky Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Distilled Drinks Drink Drugs Eye Eye Care Eye Care Products
    Industries: Beverages - Wineries & Distilleries Drug Manufacturers - Major

    Recent News for ProShares MSCI EAFE Dividend Growers ETF & its Holdings

    Date Stock Title
    Nov 21 DEO JOHNNIE WALKER RENEWS SUCCESSFUL LUNAR NEW YEAR PARTNERSHIP WITH VISIONARY ARTIST JAMES JEAN
    Nov 21 DEO Diageo “to pause” Crown Royal distillery construction in Canada
    Nov 20 DEO DELEÓN Tequila Unveils Its New Campaign and Brand Platform, "Bold Spirits, Rise"
    Nov 19 DEO Diageo: No Path For Market-Beating Returns
    Nov 19 DEO Casa Redondo eyes “more muscle” with M&A on back of Safari “party drink” purchase – CEO Daniel Redondo
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
    Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
    Nov 18 DEO Analysis-Price hikes offer chance for Guinness rivals as Diageo pushes zero alcohol brew
    Nov 15 NVS FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
    Nov 15 NVS Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
    Nov 15 NVS Ouch: Why a Healthcare Selloff Really Hurts in Europe
    Nov 14 DEO Diageo Introduces Luxury Group Division to Enrich Experience
    The investment seeks investment results before fees and expenses that track the performance of the MSCI EAFE Dividend Masters Index. The index targets companies that are currently members of the MSCI EAFE Index ("MSCI EAFE") and have increased dividend payments each year for at least 10 years. It contains a minimum of 40 stocks, which are equally weighted. Under normal circumstances, the fund will invest at least 80% of its total assets in component securities (i.e., securities of the index and comparable securities that have economic characteristics that are substantially identical to the economic characteristics of the securities of the index).
    Exchange Traded Fund Dividend MSCI EAFE Msci World
    Back to the Main EFAD Page...